Under construction – not a live service
Sign in
Not yet taking people in United StatesNo phase

Studies why some people with soft tissue sarcoma do not join trials

Looks at what keeps adults with soft tissue sarcoma from joining or finishing trials.

Plain-language title generated from the registry record
Registry title: Investigative Analysis of Soft Tissue Sarcoma Clinical Trials: An Observational Study

Key facts

Where
San Francisco, United StatesSee the site

Where in United States

  • Power Life SciencesSan Francisco, United StatesNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Power Life Sciences Inc.
Trial code
NCT06264505
Record updated
28 February 2024
Original description
Generally, specific demographic cohorts exhibit higher participation rates in medical research, yet there exists a scarcity of research elucidating the trial attributes impacting the engagement of these particular demographics.Read full original descriptionShow less

Probing Participation in Soft Tissue Sarcoma Research: An Observational Study of Soft Tissue Sarcoma Clinical Trials

Generally, specific demographic cohorts exhibit higher participation rates in medical research, yet there exists a scarcity of research elucidating the trial attributes impacting the engagement of these particular demographics.

The primary objective of this study is to gather extensive data on the clinical trial experiences of individuals diagnosed with soft tissue sarcoma, with the aim of identifying factors hindering patient enrollment or trial completion.

Inclusion: Patients diagnosed with soft tissue sarcoma; Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed; Subjects willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examination.

Exclusion: Any serious and/or unstable pre-existing medical disorders; Refusal of consent; Women of childbearing potential without a negative pregnancy test; or women who are lactating.

ClinicalTrials.gov NCT06264505